Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

New Hope for Preventing Spread and Treating Prostate Cancer

New Hope for Preventing Spread and Treating Prostate Cancer

Prostate cancer is the second most common cancer in men in our country after lung cancer. Revolutionary advances have substantially reduced deaths from this disease: 5-year survival in localized prostate cancer exceeds %98. However, deaths remain numerous in prostate cancer that has spread throughout the body (metastatic). Preventing spread and progression would therefore represent one of the greatest revolutions in fighting prostate cancer. This article shares an important development in this area.

A study in America discovered that a molecule called DNA-PKcs is the main regulator of pathways causing prostate cancer to spread to distant tissues (metastasis). It was described as an important target for developing drugs to prevent spread in prostate and other cancers.

In cancer spread through blood, cells made more mobile by certain DNA abnormalities (mutations) enter the bloodstream, travel elsewhere in the body, attach and settle there, causing new tumor sites to develop.

DNA-PKcs is a repair enzyme responsible for repairing and rejoining damaged, broken DNA strands in the body. A recently published study found that it also tries to repair damaged cancer cells, preventing their destruction by the body . It was also more active in patients with hormone-resistant prostate cancer, suggesting a possible role in resistance to hormonal therapy. The research team states it has developed a drug blocking DNA-PKcs and clinical studies are ongoing. We will follow the study and certainly share its results when completed.

In conclusion, this study is an important development for preventing spread and treating prostate and other cancers. If effectiveness is clarified in coming years, measuring blood DNA-PKcs could help predict cancer spread early and take precautions before it happens. Drugs targeting this enzyme could also prevent and treat spread. However, its role in normal DNA repair as well as cancer spread creates a challenge for clinical use. If future studies overcome this difficulty, an important weapon for preventing and treating advanced disease will have been gained.

Sources

Jonathan F. Goodwin, Vishal Kothari, Justin M. Drake.
DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.
Cancer Cell, 13 July 2015. DOI: https://dx.doi.org/10.1016/j.ccell.2015.06.004

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

New Hope for Preventing Spread and Treating Prostate Cancer

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy